E-Prescribing: Clinical Implications for Patients with Diabetes
AUTOR(ES)
Smith, Marie
FONTE
Diabetes Technology Society
RESUMO
With the recent Center for Medicare and Medicaid Services and stimulus package incentives for health information technology, many clinicians are expected to adopt or enhance their use of e-prescribing systems. E-prescribing has nearly eradicated medication errors resulting from prescriber handwriting interpretations, yet several other patient-care and workflow benefits still remain a promise. As prescribers select or update their e-prescribing systems (whether stand-alone or integrated with electronic health records), close attention is needed to the e-prescribing application features and level of clinical decision support to avoid clinical blind spots, including incomplete or inaccurate patient medication lists, poor drop-down menu or screen design, and lack of clinically relevant and actionable drug interaction and drug allergy alerts. This article presents three case studies that highlight common e-prescribing problems involving diabetes patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2769896Documentos Relacionados
- Nephrology: 3. Safe drug prescribing for patients with renal insufficiency
- Clinical syndromes seem adequate for targeting drug prescribing
- Predictive factors of subjective sleep quality and insomnia complaint in patients with stroke: implications for clinical practice
- Precordial ST segment depression in patients with inferior myocardial infarction: clinical implications.
- Clinical review: A paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome